{"id":72162,"date":"2026-08-10T13:07:39","date_gmt":"2026-08-10T05:07:39","guid":{"rendered":"https:\/\/flcube.com\/?p=72162"},"modified":"2026-08-10T13:07:40","modified_gmt":"2026-08-10T05:07:40","slug":"wuxi-apptec-wins-preliminary-injunction-against-dod-1260h-designation","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=72162","title":{"rendered":"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>WuXi AppTec Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/603259:SHA\">SHA:\u202f603259<\/a>, <a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/2359:HKG\">HKG:\u202f2359<\/a>) announced that the <strong>U.S. District Court for the District of Columbia<\/strong> has ruled in its favor regarding a lawsuit filed on <strong>June\u202f12, 2026<\/strong>, challenging its inclusion on the <strong>U.S. Department of Defense Section\u202f1260H List<\/strong>. The court granted WuXi AppTec\u2019s request for a <strong>preliminary injunction<\/strong>, barring the DoD from executing, enforcing, or acting upon the designation while judicial proceedings remain ongoing.<\/p>\n\n\n\n<h2 id=\"h-legal-milestone\" class=\"wp-block-heading\">Legal Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>WuXi AppTec Co., Ltd. (SHA:\u202f603259, HKG:\u202f2359)<\/td><\/tr><tr><td><strong>Court<\/strong><\/td><td>U.S. District Court for the District of Columbia<\/td><\/tr><tr><td><strong>Case Origin<\/strong><\/td><td>Lawsuit filed June\u202f12, 2026<\/td><\/tr><tr><td><strong>Ruling<\/strong><\/td><td>Preliminary injunction granted in favor of WuXi AppTec<\/td><\/tr><tr><td><strong>Subject<\/strong><\/td><td>Challenge to DoD Section\u202f1260H designation<\/td><\/tr><tr><td><strong>Effective Restraint<\/strong><\/td><td>DoD barred from executing, enforcing, or acting upon the 1260H listing<\/td><\/tr><tr><td><strong>Duration<\/strong><\/td><td>Effective for the duration of ongoing litigation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-case-background\" class=\"wp-block-heading\">Case Background<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>1260H Designation:<\/strong> The National Defense Authorization Act\u2019s Section\u202f1260H authorizes the DoD to identify companies allegedly operating as <strong>&#8220;Chinese military companies&#8221;<\/strong> (CMCs), triggering restrictions on U.S. government procurement, contracts, and in certain cases, secondary market impacts.<\/li>\n\n\n\n<li><strong>WuXi AppTec\u2019s Position:<\/strong> The company has consistently denied any military affiliation, asserting that its business is confined to <strong>pharmaceutical and biotechnology contract research, development, and manufacturing services (CRDMO)<\/strong>.<\/li>\n\n\n\n<li><strong>Legal Strategy:<\/strong> The June\u202f12 filing sought judicial review of the administrative designation, arguing procedural deficiencies and lack of evidentiary support. The preliminary injunction represents an early procedural victory in what is expected to be a protracted litigation.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Immediate Relief:<\/strong> The injunction effectively <strong>shields WuXi AppTec from immediate adverse impacts<\/strong> tied to the 1260H designation for the duration of the court proceedings, removing near\u2011term uncertainty around U.S. federal contract eligibility and potential downstream investor restrictions.<\/li>\n\n\n\n<li><strong>Geopolitical Risk Mitigation:<\/strong> For global biopharma clients \u2014 many of whom rely on WuXi AppTec for small\u2011molecule and cell\u2011gene therapy manufacturing \u2014 the ruling reduces the risk of supply\u2011chain disruption or forced vendor transitions. Several multinational pharmas had reportedly initiated contingency planning following the initial listing.<\/li>\n\n\n\n<li><strong>Share Price Reaction:<\/strong> WuXi AppTec\u2019s dual\u2011listed shares are expected to react positively to the news, as the preliminary injunction delays enforcement and signals judicial willingness to scrutinize the DoD\u2019s designation rationale.<\/li>\n\n\n\n<li><strong>Broader Precedent:<\/strong> The ruling could influence the legal trajectory of other Chinese biotech and healthcare services companies facing similar 1260H or related U.S. government listings, potentially encouraging more entities to pursue judicial remedies rather than administrative appeals alone.<\/li>\n\n\n\n<li><strong>Next Steps:<\/strong> The underlying litigation challenging the substantive validity of the 1260H designation will continue. A full trial on the merits could take <strong>12\u201324 months<\/strong>, during which the preliminary injunction remains in force absent appellate reversal.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the legal and commercial implications of the preliminary injunction and ongoing litigation. Actual outcomes may differ materially due to appellate rulings, changes in U.S. administrative policy, legislative amendments to Section\u202f1260H, and broader geopolitical developments. The preliminary injunction does not constitute a final judgment on the merits. Investors should consult official filings and legal counsel for updated risk factors.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>WuXi AppTec Co., Ltd. (SHA:\u202f603259, HKG:\u202f2359) announced that the U.S. District Court for the District&#8230;<\/p>\n","protected":false},"author":1,"featured_media":72163,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[61],"tags":[19,951,1078,362],"class_list":["post-72162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-legal-ip","tag-cro-cmo-cdmo","tag-hkg-2359","tag-sha-603259","tag-wuxi-apptec"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"WuXi AppTec Co., Ltd. (SHA:\u202f603259, HKG:\u202f2359) announced that the U.S. District Court for the District of Columbia has ruled in its favor regarding a lawsuit filed on June\u202f12, 2026, challenging its inclusion on the U.S. Department of Defense Section\u202f1260H List. The court granted WuXi AppTec\u2019s request for a preliminary injunction, barring the DoD from executing, enforcing, or acting upon the designation while judicial proceedings remain ongoing.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=72162\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation\" \/>\n<meta property=\"og:description\" content=\"WuXi AppTec Co., Ltd. (SHA:\u202f603259, HKG:\u202f2359) announced that the U.S. District Court for the District of Columbia has ruled in its favor regarding a lawsuit filed on June\u202f12, 2026, challenging its inclusion on the U.S. Department of Defense Section\u202f1260H List. The court granted WuXi AppTec\u2019s request for a preliminary injunction, barring the DoD from executing, enforcing, or acting upon the designation while judicial proceedings remain ongoing.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=72162\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-10T05:07:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-10T05:07:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1003.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation\",\"datePublished\":\"2026-08-10T05:07:39+00:00\",\"dateModified\":\"2026-08-10T05:07:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162\"},\"wordCount\":519,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1003.webp\",\"keywords\":[\"CRO \\\/ CMO \\\/ CDMO\",\"HKG: 2359\",\"SHA: 603259\",\"WuXi AppTec\"],\"articleSection\":[\"Legal \\\/ IP\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72162#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=72162\",\"name\":\"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1003.webp\",\"datePublished\":\"2026-08-10T05:07:39+00:00\",\"dateModified\":\"2026-08-10T05:07:40+00:00\",\"description\":\"WuXi AppTec Co., Ltd. (SHA:\u202f603259, HKG:\u202f2359) announced that the U.S. District Court for the District of Columbia has ruled in its favor regarding a lawsuit filed on June\u202f12, 2026, challenging its inclusion on the U.S. Department of Defense Section\u202f1260H List. The court granted WuXi AppTec\u2019s request for a preliminary injunction, barring the DoD from executing, enforcing, or acting upon the designation while judicial proceedings remain ongoing.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72162\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1003.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1003.webp\",\"width\":1080,\"height\":608,\"caption\":\"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72162#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation - Insight, China&#039;s Pharmaceutical Industry","description":"WuXi AppTec Co., Ltd. (SHA:\u202f603259, HKG:\u202f2359) announced that the U.S. District Court for the District of Columbia has ruled in its favor regarding a lawsuit filed on June\u202f12, 2026, challenging its inclusion on the U.S. Department of Defense Section\u202f1260H List. The court granted WuXi AppTec\u2019s request for a preliminary injunction, barring the DoD from executing, enforcing, or acting upon the designation while judicial proceedings remain ongoing.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=72162","og_locale":"en_US","og_type":"article","og_title":"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation","og_description":"WuXi AppTec Co., Ltd. (SHA:\u202f603259, HKG:\u202f2359) announced that the U.S. District Court for the District of Columbia has ruled in its favor regarding a lawsuit filed on June\u202f12, 2026, challenging its inclusion on the U.S. Department of Defense Section\u202f1260H List. The court granted WuXi AppTec\u2019s request for a preliminary injunction, barring the DoD from executing, enforcing, or acting upon the designation while judicial proceedings remain ongoing.","og_url":"https:\/\/flcube.com\/?p=72162","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-10T05:07:39+00:00","article_modified_time":"2026-08-10T05:07:40+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1003.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=72162#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=72162"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation","datePublished":"2026-08-10T05:07:39+00:00","dateModified":"2026-08-10T05:07:40+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=72162"},"wordCount":519,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=72162#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1003.webp","keywords":["CRO \/ CMO \/ CDMO","HKG: 2359","SHA: 603259","WuXi AppTec"],"articleSection":["Legal \/ IP"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=72162#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=72162","url":"https:\/\/flcube.com\/?p=72162","name":"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=72162#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=72162#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1003.webp","datePublished":"2026-08-10T05:07:39+00:00","dateModified":"2026-08-10T05:07:40+00:00","description":"WuXi AppTec Co., Ltd. (SHA:\u202f603259, HKG:\u202f2359) announced that the U.S. District Court for the District of Columbia has ruled in its favor regarding a lawsuit filed on June\u202f12, 2026, challenging its inclusion on the U.S. Department of Defense Section\u202f1260H List. The court granted WuXi AppTec\u2019s request for a preliminary injunction, barring the DoD from executing, enforcing, or acting upon the designation while judicial proceedings remain ongoing.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=72162#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=72162"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=72162#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1003.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1003.webp","width":1080,"height":608,"caption":"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=72162#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1003.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=72162"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72162\/revisions"}],"predecessor-version":[{"id":72165,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72162\/revisions\/72165"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/72163"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=72162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=72162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=72162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}